Fecal RNA detection of cytokeratin 19 and ribosomal protein L19 for colorectal cancer

Hepato-Gastroenterology

Volumn 57, Issue 101, 2010, Pages 710-715

  Yang, Shung Haur ^a   Huang, Chi Jung ^b,c   Lee, Chia Long ^c   Liu, Chen Chiung ^c   Chien, Chih Cheng ^d   Chen, Shu Hung ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Cytokeratin 19; Fecal RNA; L19; Molecular marker; Prognosis; Ribosomal protein

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA; RIBOSOMAL PROTEIN L19; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE INTERVAL; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; FECES; FEMALE; HUMANS; KERATIN-19; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78149248852     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al: Cancer statistics. 2004. CA Cancer J Clin 2004; 54:8-29.
2. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS: CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004; 10:2351-2358. (Pubitemid 38445693)
3. Gradilone A, Gazzaniga P, Silvestri I, Gandini O, Trasatti L, Lauro S, et al: Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. Oncol Rep 2003; 10:217-222.
4. Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33:49-54.
5. Lagerholm S, Lagerholm S, Dutta S, Nair P: Non-invasive detection of c-myc p64, c-myc p67 and c-erbb-2 in colorectal cancer. Scand J Gastroenterol 2005; 40:1343-1350.
6. Davies RJ, Miller R, Coleman N: Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005; 5:199-209.
7. Haug U, Brenner H: A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy. Cancer Epidemiol Biomarkers Prev 2005; 14:422-428. (Pubitemid 40270107)
8. Whitney D, Skoletsky J, Moore K, Boynton K, Kann L, Brand R, et al: Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diag 2004; 6:386-395.
9. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJJ, et al: Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002; 346:311-320.
10. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, et al: Detecting colorectal cancer in stool with the use of multiple genetic targets J Natl Cancer Inst 2001; 93:858-865.
11. Yang SH, Chien CC, Chen CW, Li SY, Huang CJ: Potential of faecal RNA in diagnosing colorectal cancer. Cancer Lett. 2005; 226:55-63.
12. Galan M, Vinolas N, Colomer D, Soler G, Munoz M, Longaron R, et al: Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation. Anticancer Res 2002; 22:2877-2884.
13. Albaugh GP, Iyengar V, Lohani A, Malayeri M, Bala S, Nair PP: Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers. Int J Cancer 1992; 52:347-350.
14. Baricault L, de Nechaud B, Sapin C, Codogno P, Denoulet P, Trugnan G: The network organization and the phosphorylation of cytokeratins are concomitantly modified by forskolin in the enterocyte-like differentiated Caco-2 cell line. J Cell Sci 1994; 107:2909-2918. (Pubitemid 24340910)
15. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, et al: Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer. 1997; 74:540-544.
16. Wong IH, Yeo W, Chan AT, Johnson PJ: Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett 2001; 162:65-73.
17. Huang CJ, Chien CC, Yang SH, Chang CC, Sun HL, Cheng YC, et al: Fecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer. J Cell Mol Med 2008; 4:4.
18. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, et al: Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterol 2000; 119:1219-1227.
19. Tao L, Lefevre M, Ricci S, Saintigny P, Callard P, Perie S, et al: Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA. Br J Cancer 2006; 94:1164-1169.
20. th ed) Chicago, IL, Springer 2002.
21. Chien CC, Chang CC, Yang SH, Chen SH, Huang CJ: A homologue of the Drosophila headcase protein, HECA, is a novel tumor marker for early-stage colorectal cancer. Oncol Rep 2006;15:919-926.
22. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45.
23. de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, et al: Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 2005; 85:154-159.
24. Takehisa J, Kraus MH, Decker JM, Li Y, Keele BF, Bibollet-Ruche F, et al: Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. J Virol 2007; 81:7463-7475.
25. Ji Y, Zhu Y, Liang J, Wei X, Yang X, Wang L, et al: Swine hepatitis E virus in rural southern China: genetic characterization and experimental infection in rhesus monkeys (Macaca mulatta). J Gastroenterol 2008; 43:565-570.
26. Yu YJ, Majumdar AP, Nechvatal JM, Ram JL, Basson MD, Heilbrun LK, et al: Exfoliated cells in stool: a source for reverse transcription-PCR-based analysis of biomarkers of gastrointestinal cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:455-458.
27. Bartek J, Bartkova J, Taylor-Papadimitriou J, Rejthar A, Kovarik J, Lukas Z, et al: Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J 1986; 18:565-575.
28. Tobias-Machado M, Fonseca F, Fantinato AP, Bendit I, Wroclawski ML, Wroclawski E, et al: Cytokeratin 19 expression by reverse transcriptase- polymerase chain reaction in the peripheral blood of prostate cancer patients. Tumori. 2005; 91:248-252.
29. Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M: Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 2005; 92:906-912.
30. Benoy IH, Elst H, Van der Auwera I, Van Laere S, van Dam P, Van Marck E, et al: Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer. Br J Cancer. 2004; 91:1813-1820.
31. Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, et al: Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 2003; 94:851-857.
32. Silva JM, Rodriguez R, Garcia JM, Munoz C, Silva J, Dominguez G, et al: Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002; 50:530-534.
33. Li M, Xiao ZQ, Chen ZC, Li JL, Li C, Zhang PF, et al: Proteomic analysis of the aging-related proteins in human normal colon epithelial tissue. J Biochem Mol Biol 2007; 40:72-81.
34. Kobayashi T, Sasaki Y, Oshima Y, Yamamoto H, Mita H, Suzuki H, et al: Activation of the ribosomal protein L13 gene in human gastrointestinal cancer Int J Mol Med 2006; 18:161-170.
35. Shi Y, Zhai H, Wang X, Han Z, Liu C, Lan M, et al: Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp Cell Res 2004; 296:337-346.
36. Gunderson LL: Indications for and results of combined modality treatment of colorectal cancer. Acta Oncol 1999; 38:7-21. (Pubitemid 29119243)
37. Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S: Association between colonic screening, subject characteristics, and stage of colorectal cancer. Am J Gastroenterol 2005; 100:2531-2539.
38. Jestin P, Pahlman L, Glimelius B, Gunnarsson U: Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer 2005; 41:2071-2078.
39. Bustin SA, Dorudi S: Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Expert Rev Mol Diagn 2004; 4:599-607.